Yuzhong Chen

发表

Definition of a new blood cell count score for early survival prediction for non-small cell lung cancer patients treated with atezolizumab: Integrated analysis of four multicenter clinical trials

D. Schrump, R. Fietkau, Jian-Guo Zhou, 2021, Frontiers in Immunology.

Combination of Tertiary Lymphoid Structure and Neutrophil-to-Lymphocyte Ratio Predicts Survival in Patients With Hepatocellular Carcinoma

Miaolin Zhu, B. Shen, S. Wen, 2022, Frontiers in Immunology.

Association of Dynamic Changes in Peripheral Blood Indexes With Response to PD-1 Inhibitor-Based Combination Therapy and Survival Among Patients With Advanced Non-Small Cell Lung Cancer

B. Shen, Ban-zhou Pan, S. Wen, 2021, Frontiers in Immunology.

Four differentially expressed genes can predict prognosis and microenvironment immune infiltration in lung cancer: a study based on data from the GEO

S. Wen, B. Shen, Guoren Zhou, 2022, BMC Cancer.

Four differentially expressed genes can predict prognosis and microenvironment immune infiltration in lung cancer: a study based on data from the GEO

S. Wen, Guoren Zhou, Weiwei Peng, 2022, BMC cancer.

Efficacy and safety of first-generation epidermal growth factor receptor (EGFR) tyrosine kinase inhibitors (TKIs) combined with chemotherapy or antiangiogenic therapy as first-line treatment in patients with EGFR-mutant non-small cell lung cancer: A systematic review and meta-analysis.

B. Shen, S. Wen, Yuan Wu, 2021, Critical reviews in oncology/hematology.

Tobacco exposure primes the secretion of CCL21 positively associated with tertiary lymphoid structure and response to immunotherapy

Lin Xu, Gaochao Dong, W. Xia, 2023, Journal for ImmunoTherapy of Cancer.

外周血炎症指标作为预测性指标在晚期非小细胞肺癌免疫治疗中的应用

B. Shen, S. Wen, Yuzhong Chen, 2021, Zhongguo fei ai za zhi = Chinese journal of lung cancer.

The super-enhancer-driven lncRNA LINC00880 acts as a scaffold between CDK1 and PRDX1 to sustain the malignance of lung adenocarcinoma

Lin Xu, Gaochao Dong, W. Xia, 2023, Cell death & disease.